KRYSTAL ABUCEVICZ-SWICK: Open Payments
NPI 1750867362 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 10 payments from 5 companies in 2025. Trend: 2023 $19 · 2024 $234 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $64 |
| Organogenesis Inc. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Verona Pharma, Inc. | 1 | $27 |
| CashFlow Solutions, LLC | 1 | $18 |
Products named: NUCALA, PURAPLY WOUND MATRIX, Ohtuvayre, TEZSPIRE, LYMPHA PRESS OPTIMAL PLUS(US) BT, FASENRA, APLIGRAF.
Industry payments across MD — which companies pay providers there.
